WHO合理用药调研方法幻灯片.pptVIP

Implementing a Drug Use Indicators Study 合理用药调研方法 翟所迪 zhaisuodi@263.net 北医三院 World Health Organization HOW TO DEVELOP A NATIONAL FORMULARY BASED ON THE WHO MODEL FORMULARY A practical guide Dextran 70 Dextran is a representative plasma substitute. Various preparations can serve as alternatives Infusion (Solution for infusion), dextran 70 6% in glucose intravenous infusion 5% or sodium chloride intravenous infusion 0.9% Uses: short-term blood volume expansion Contraindications: severe congestive heart failure, renal failure; bleeding disorders such as thrombocytopenia and hypofibrinogenae